Artificial intelligence (AI) is entering the mainstream. The term encompasses a wide variety of machines that can learn from data, identify patterns, and make decisions. But how can it be used to support health care? EULAR—The ...
Jun 16, 2025
0
0
The Very Early Diagnosis of Systemic Sclerosis (VEDOSS) criteria identify red flags as puffy fingers, abnormal nailfold capillaroscopy, and specific autoantibodies in patients with Raynaud's phenomenon as a very early disease ...
Jun 12, 2025
0
0
Patients with systemic sclerosis or Sjögren's syndrome suffer from various inflammatory reactions triggered by the body's own immune system. A team of researchers has investigated the role of certain immune cells in the ...
May 27, 2025
0
0
A multidisciplinary clinical team led by Professor Bernat Soria from the Institute of Bioengineering at the Miguel Hernández University of Elche (UMH, Spain) has developed a new method to deliver cell therapies in patients ...
Apr 16, 2025
0
57
A new cancer drug called trastuzumab deruxtecan, also known as Enhertu, has just been approved in the UK. This drug is designed to help adults with certain types of advanced cancer that cannot be removed by surgery, or which ...
Apr 15, 2025
0
0
Women are less likely to receive a lung transplant and spend an average of six weeks longer on the waiting list, according to a study published in ERJ Open Research. However, women who receive a lung transplant are more likely ...
Jan 9, 2025
0
0
For asymptomatic rheumatoid arthritis (RA) patients, a new radiation-free screening protocol can identify suspected interstitial lung involvement (ILI), according to a study published online Nov. 23 in BMC Pulmonary Medicine.
Dec 6, 2024
0
0
About 32% of people who have had prior damage from lung diseases will die after five years if they also get a common fungal infection, a major global review has found. The review also finds that 15% of people with chronic ...
Nov 29, 2024
0
0
Dr. Watanabe and his team from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, known as a serious side effect of immunotherapy ...
Nov 13, 2024
0
0
A team of researchers have applied a novel blood test that can detect early signs of potentially fatal lung damage in cancer patients taking antibody–drug conjugates (ADCs). This breakthrough method aims to offer a safer, ...
Nov 12, 2024
0
0
Interstitial lung disease (ILD), also known as diffuse parenchymal lung disease (DPLD), refers to a group of lung diseases affecting the interstitium (the tissue and space around the air sacs of the lungs). It concerns alveolar epithelium, pulmonary capillary endothelium, basement membrane, perivascular and perilymphatic tissues.
The term ILD is used to distinguish these diseases from obstructive airways diseases.
Prolonged ILD may result in pulmonary fibrosis, but this is not always the case. Idiopathic pulmonary fibrosis is one form of "interstitial lung disease".
This text uses material from Wikipedia licensed under CC BY-SA
